Role of exercise cardiac index to predict NYHA functional class, 6-minute walk test distance and survival in idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension

R. Poncot-Mongars, A. Chaouat, P. Malvestio, E. Gomez, D. Regent, C. Selton, A. Guillaumot, F. Chabot (Vandoeuvre-lès-Nancy, France)

Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Session: Physiology of human pulmonary hypertension
Session type: Thematic Poster Session
Number: 2300
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Poncot-Mongars, A. Chaouat, P. Malvestio, E. Gomez, D. Regent, C. Selton, A. Guillaumot, F. Chabot (Vandoeuvre-lès-Nancy, France). Role of exercise cardiac index to predict NYHA functional class, 6-minute walk test distance and survival in idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension. Eur Respir J 2011; 38: Suppl. 55, 2300

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension
Source: Eur Respir J 2012; 40: 1410-1419
Year: 2012



The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension
Source: Eur Respir J 2010; 36: 1294-1301
Year: 2010



Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension
Source: Eur Respir J 2006; 27: 114-120
Year: 2006



Maximal cardiopulmonary exercise testing in mildly symptomatic patients with idiopathic pulmonary arterial hypertension: correlations with 6-min walk distance and resting hemodynamics
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009

The 6-min walk distance: change over time and value as a predictor of survival in severe COPD
Source: Eur Respir J 2004; 23: 28-33
Year: 2004



The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension
Source: Eur Respir Rev 2013; 22: 487-494
Year: 2013



The prognostic value of percent predicted six-minute walk distance in pulmonary arterial hypertension
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Year: 2009




Is 6-minute walk distance (6MWD) associated with long-term outcomes in pulmonary arterial hypertension (PAH)? Results from SERAPHIN
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

The 6-minute walk test adjusted for peak heart rate correlates with stroke volume index in pulmonary arterial hypertension
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004


6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 1822-1823
Year: 2014


6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 1823-1824
Year: 2014


Cardiopulmonary exercise test unveils abnormal exercise physiology in patients affected by pulmonary arterial hypertension with a low-risk profile 6 minute walk distance.
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020


6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 1421-1429
Year: 2014



6-minute walk test predicts pulmonary artery pressure in patients with collagen vascular disease associated interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012


Effects of sildenafil on 6-minute walk distance (6MWD) and WHO functional class (FC) in pulmonary arterial hypertension (PAH) patients after 1 year of treatment
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005


Physiological response to the six-minute walk test in pulmonary arterial hypertension
Source: Eur Respir J 2005; 26: 667-672
Year: 2005



Exercise testing in pulmonary arterial hypertension and in chronic heart failure
Source: Eur Respir J 2004; 23: 747-751
Year: 2004



Relationship between sit-to-stand test and six-minute walk test in patients with pulmonary arterial hypertension
Source: International Congress 2015 – The challenge of choosing the best physical and functional assessment methods
Year: 2015

Spiroveloergometry and 6-minute walking test for exercise capacity assessment in patients with primary pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 16s
Year: 2005

The clinical relevance of heart rate increase in the interpretation of six-minute walk test in pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012